What is it about?
A novel antibacterial peptide from Crocodylus siamensis hemoglobin hydrolysate (CHHs) was characterised for antimicrobial activity. The QAIIHNEKVQAHGKKVL fragment of Crocodylus siamensis hemoglobin is antibacterial via a mechanism that likely relies on iron dysregulation and oxidative stress which results in bacterial death. We have described for the first time, a novel peptide derived from Crocodylus siamensis hemoglobin hydrolysate, that has the potential to be developed as a novel antimicrobial peptide.
Featured Image
Why is it important?
We have described for the first time, a novel peptide derived from Crocodylus siamensis hemoglobin hydrolysate, that has the potential to be developed as a novel antimicrobial peptide.
Perspectives
Writing this article was an awesome pleasure for me as a first author and all of co-authors as well. We are described for the first time that natural resource hemoglobin hydrolysate derived from Siamese crocodile (Crocodylus siamensis) could be developed as a new therapeutic agent for treating bacterial infection.
Dr Jiraporn Lueangsakulthai
Oregon State University
Read the Original
This page is a summary of: A novel antibacterial peptide derived from Crocodylus siamensis
haemoglobin hydrolysate induces membrane permeabilization causing iron dysregulation, oxidative stress and bacterial death, Journal of Applied Microbiology, September 2017, Wiley,
DOI: 10.1111/jam.13539.
You can read the full text:
Contributors
The following have contributed to this page
